Navigation Links
United Therapeutics Corporation Reports Second Quarter 2011 Financial Results
Date:7/28/2011

t Reports on Form 8-K.  We claim the protection of the safe harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements. We are providing this information as of July 28, 2011, and assume no obligation to update or revise the information contained in this press release whether as a result of new information, future events or any other reason. [uthr-g]

Remodulin and Tyvaso are registered trademarks of United Therapeutics Corporation.

Adcirca is a registered trademark of Eli Lilly and Company.

UNITED THERAPEUTICS CORPORATIONCONSOLIDATED STATEMENTS OF OPERATIONS(In thousands, except per share data)Three Months EndedJune 30,Six Months EndedJune 30,2011201020112010(Unaudited)(Unaudited)Revenues:Net product sales

$

183,546$

134,439$

345,764$

260,071License fees

205282499564Total revenues

183,751134,721346,263260,635Operating expenses:Research and development

24,24028,58771,94763,055Selling, general and administrative

23,85629,65482,11875,106Cost of product sales

21,16215,26140,90028,984Total operating expenses

69,25873,502194,965167,145Operating income

114,49361,219151,29893,490Other (expense) income:Interest income

8398021,5041,746Interest expense

(5,431)(4,759)(10,841)(9,446)Equity loss in affiliate

(30)(44)(67)(91)Other, net

(257)93(1,023)318Total other (expense) income, net

(4,879)(3,908)(10,427)(7,473)Income from continuing operations before income taxes

109,61457,311140,87186,017Income tax expense

(35,723)(19,345)(47,622)(29,106)Income from continuing operations

73,89137,96693,24956,911Discontinued operations:(Loss) income from discontinued operations, net of tax

—(259)76(275)Loss on disposal of discontinued operations, net of tax

——(3,044)—Loss from discontinued operations

—(259)(2,968)(275)N
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. FDA Advisory Panel Unanimously Recommends Approval of EXCOR(R) Pediatric Ventricular Assist Device for Use in the United States
2. Daiichi Sankyo Selects Veeva CRM to Support Customer Engagement Initiatives in the United Kingdom
3. United Therapeutics Corporation To Announce Second Quarter 2011 Financial Results Before Market Open on Thursday, July 28, 2011
4. United Therapeutics Corporation Completes Enrollment of FREEDOM-C(2) Trial
5. United Therapeutics Corporation Reports 2010 Fourth Quarter and Annual Financial Results
6. United Therapeutics Corporation to Announce Fourth Quarter and Annual 2010 Financial Results Before Market Open on Tuesday, February 15, 2011
7. United Therapeutics Corporation Reports Third Quarter 2010 Financial Results
8. United Therapeutics Corporation to Announce Third Quarter 2010 Financial Results Before Market Open on Thursday, October 28, 2010
9. Sangart, Inc. Receives $1.1 Million Grant Award from the United States Department of Defense for Further Development of MP4 Molecule in Trauma
10. United Therapeutics Corporation to Announce Second Quarter 2010 Financial Results Before Market Open on Wednesday, July 28, 2010
11. Report Details How States Respond to Citizens United Decision
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... Parsippany, NJ (PRWEB) July 22, 2014 ... analytical, precision, portable, and mechanical balances and scales, ... precision balances has won Laboratory Equipment magazine’s 2014 ... is the second consecutive year the Explorer was ... readers. The annual Readers’ Choice Awards celebrates “excellence ...
(Date:7/22/2014)... and SHENZHEN, China , ... Co., LTD, (BGI Tech), a subsidiary of BGI, ... global launch of a new human whole exome ... This newly offered service includes in-depth bioinformatics analysis ... prices until December 31, 2014. ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Quorum Review IRB, ... service for large clinical trials called Quick Step™ . ... designed to address the research industry’s need for seamless study ... service is available for studies planning 50 or more North ... combined planned North American site count of 80 or more. ...
(Date:7/22/2014)... 2014 The next session of ... and will comprise of the increasingly popular ‘Base SAS’ ... is a series of technical hands-on classes for entry-level ... reach the next step in their professional careers. , ... by Jennifer Kang, Senior Statistician at Genentech and former ...
Breaking Biology Technology:OHAUS Explorer Voted “Best Balance” in Laboratory Equipment’s 2014 Readers’ Choice Awards 2BGI Tech Launches Human Whole Exome Sequencing Service on Complete Genomics' Advanced Platform 2BGI Tech Launches Human Whole Exome Sequencing Service on Complete Genomics' Advanced Platform 3Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 2Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 3Clinovo TechTrainings: Next Session of SAS and CDISC Classes Start 9th September, 2014 2Clinovo TechTrainings: Next Session of SAS and CDISC Classes Start 9th September, 2014 3
... March 21, 2011 Cell Therapeutics, Inc. ("CTI") (Nasdaq ... its randomized pivotal trial of pixantrone for the treatment ... trial is now open to patient enrollment. The trial, ... will compare a combination of pixantrone plus rituximab to ...
... 18, 2011 Driving value for customers is critical to ... points between a customer and an organization, there has to ... an organization to succeed in the marketplace. ... Practices, LLC., noted in this month,s special issue of PharmaVoice ...
... 2011 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ... Approach for PKU Treatment) in an abstract (Abstract #91 ... presented by Barbara Burton, MD at the 2011 annual ... Canada.  ADAPT, which was funded by a grant from ...
Cached Biology Technology:Cell Therapeutics Initiates Pixantrone PIX-R Pivotal Trial for Treatment of Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma 2Cell Therapeutics Initiates Pixantrone PIX-R Pivotal Trial for Treatment of Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma 3Cell Therapeutics Initiates Pixantrone PIX-R Pivotal Trial for Treatment of Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma 4Best Practices, LLC Showcases Its Expertise in Customer Relationship Management 2First-of-Its-Kind Study Suggests Importance of Routine Mental Health Screening in the Care of Patients Suffering From Genetic Disease PKU 2First-of-Its-Kind Study Suggests Importance of Routine Mental Health Screening in the Care of Patients Suffering From Genetic Disease PKU 3First-of-Its-Kind Study Suggests Importance of Routine Mental Health Screening in the Care of Patients Suffering From Genetic Disease PKU 4First-of-Its-Kind Study Suggests Importance of Routine Mental Health Screening in the Care of Patients Suffering From Genetic Disease PKU 5First-of-Its-Kind Study Suggests Importance of Routine Mental Health Screening in the Care of Patients Suffering From Genetic Disease PKU 6First-of-Its-Kind Study Suggests Importance of Routine Mental Health Screening in the Care of Patients Suffering From Genetic Disease PKU 7First-of-Its-Kind Study Suggests Importance of Routine Mental Health Screening in the Care of Patients Suffering From Genetic Disease PKU 8
(Date:7/22/2014)... purified crystals that split light with uncanny precision ... and, potentially, computers that manipulate light instead of ... such as etching them with a precise beam ... , Now, researchers at Princeton and Columbia universities ... scientists to customize and grow these specialized materials, ...
(Date:7/22/2014)... milk helps make their bones strong or that fish is food ... if something is good for us, it must surely taste bad? ... Research , when children hear about the benefits of healthy food, ... food is presented to children as making them strong or as ... read or count, they would conclude the food is not as ...
(Date:7/22/2014)... trees and not just asphalt and recreation equipment reduces ... Colorado Boulder study. , Working on class assignments or ... youth, according to a paper published in the journal ... of the first of its kind to focus on ... stress. , "Many schools already offer stress management programs, ...
Breaking Biology News(10 mins):Technique simplifies the creation of high-tech crystals 2Technique simplifies the creation of high-tech crystals 3Natural-terrain schoolyards reduce children's stress, says Colorado University-Boulder study 2Natural-terrain schoolyards reduce children's stress, says Colorado University-Boulder study 3
... of Medicine (BUSM) have demonstrated that certain T cells ... pro-inflammatory response in people with type 2 diabetes (T2D). ... a loss in homeostasis in this group of T ... Barbara Nikolajczyk, PhD, an associate professor of ...
... the winners of its international travel grants to ... the Baltimore Convention Center in Baltimore, Maryland, March ... is to foster and initiate further interaction between ... financial difficulties. Recipients of this competitive award ...
... rap as vermin and pests because they seem to thrive ... in Africa for the past 50 million years. From ... a stable and plentiful source of food, says paleontologist Alisa ... fossils are proving their usefulness to scientists as they help ...
Cached Biology News:Biophysical Society announces winners of 2011 International Travel Awards 2Biophysical Society announces winners of 2011 International Travel Awards 3Biophysical Society announces winners of 2011 International Travel Awards 4Rodents were diverse and abundant in prehistoric Africa when our human ancestors evolved 2Rodents were diverse and abundant in prehistoric Africa when our human ancestors evolved 3